Search
for
Sort by
Research 511–540 of 1000+
- Highly efficient nucleophilic addition of alkyl Grignard reagents to 17-ketosteroids in the presence of cerium(III) chloride: Synthesis of 17α-propyl-17β-hydroxy-4-androsten-3-one, an androgen receptor antagonist
- Cutaneous drug reactions
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- 5α-Reductase inhibitors in androgenetic alopecia
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- 5α-Reductase inhibitors in androgenetic alopecia
- Estrogens and aging skin
- Idiopathic CD4+ T-lymphocytopenia
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- IMPACTOS CAPILARES DA COVID-19 A LIGAÇÃO ENTRE EFLÚVIO TELÓGENO AGUDO E ALOPECIA AREATA: REVISÃO INTEGRATIVA
- Effects of non-contingent cocaine on 3alpha-androstanediol. I. Disruption of male sexual behavior
- Penetration and storage of particles in human skin: Perspectives and safety aspects
- Effect of 5α-Dihydrotestosterone and Testosterone on Apoptosis in Human Dermal Papilla Cells
- Finasteride, A Steroid 5α-Reductase Inhibitor, Does Not Affect the Oxidative Metabolism of Antipyrine
- The Journey of Platelet Concentrates: An Era of Regeneration in Medicine and Dentistry: A Review
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Minoxidil Cannot Be Used To Target Lysyl Hydroxylases during Postnatal Mouse Lung Development: A Cautionary Note
- Inibição seletiva da 5α-redutase e preservação da aromatase no transplante capilar
- Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood
- Synthetic studies toward the development of novel minoxidil analogs and conjugates with polyamines
- Answers to CME examination
- Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp
- Obesity and polycystic ovary syndrome
- Treatment of MSCs with Wnt1a-conditioned medium activates DP cells and promotes hair follicle regrowth
- GLI2-specific Transcriptional Activation of the Bone Morphogenetic Protein/Activin Antagonist Follistatin in Human Epidermal Cells
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects